# Fibrosing ILD Biomarkers That Rule Acceleration

> **NCT05635032** · — · UNKNOWN · sponsor: **Universidade do Porto** · enrollment: 150 (estimated)

## Conditions studied

- Pulmonary Fibrosis
- Sarcoidosis

## Interventions

- **OTHER:** Comprehensive clinical assessment and biological samples collection

## Key facts

- **NCT ID:** NCT05635032
- **Lead sponsor:** Universidade do Porto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2024-02-29
- **Final completion:** 2026-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635032, "Fibrosing ILD Biomarkers That Rule Acceleration". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05635032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*